Medicare Enrolled

Dr. Michael Machuzak, M.D.

Pulmonary Disease · Cleveland, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
9500 EUCLID AVE, Cleveland, OH 44195
8002232273
In practice since 2006 (20 years)
NPI: 1851355085 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Machuzak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Machuzak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Machuzak

Dr. Michael Machuzak is a pulmonary disease specialist in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Machuzak performed 160 Medicare services across 137 unique beneficiaries.

Between the years covered by Open Payments, Dr. Machuzak received a total of $327,532 from 25 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Machuzak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 160 Medicare services $327,532 industry payments

Medicare Practice Summary

Medicare Utilization ↗
160
Medicare services
Bottom 11% in OH for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
137
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
34 $93 $1,298
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
29 $14 $1,045
Additional lung lobe biopsy via endoscope
This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope, performed after an initial biopsy.
20 $38 $374
Endoscopic destruction of lung airway growth or narrowing
A procedure using an endoscope to destroy abnormal growths or relieve narrowing within the lung airways.
19 $185 $1,871
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $66 $419
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
15 $85 $1,397
Bronchoscopy with ultrasound and lymph node sampling
A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes.
14 $137 $1,657
New patient office visit, complex (60-74 min) 12 $139 $956
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$327,532
Total received (2018-2024)
Avg $46,790/year across 7 years
Top 1% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$216,323 (66.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$87,523 (26.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,686 (7.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$53,443
2023
$39,674
2022
$29,947
2021
$13,996
2020
$28,856
2019
$88,038
2018
$73,579

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$21,401
Ethicon Inc.
$18,589
Olympus Medical Systems Corporation
$7,150
Olympus Corporation of the Americas
$3,341
Body Vision Medical Inc.
$2,014
Olympus America Inc.
$601
Noah Medical Corporation
$152
Philips North America LLC
$97
Boston Scientific Corporation
$60
Pulmonx Corporation
$38
Top 3 companies account for 88.2% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$215,883
Ethicon Inc.
$33,873
Medical Device Business Services, Inc.
$22,272
Olympus America Inc.
$17,705
Auris Health, Inc.
$14,046
Olympus Medical Systems Corporation
$7,150
Body Vision Medical Inc.
$4,543
Gyrus ACMI, Inc.
$3,630
Pulmonx Corporation
$1,616
Ethicon Endo-Surgery Inc.
$1,471
Intuitive Surgical, Inc.
$1,205
Olympus Corporation
$1,043
BOSTON SCIENTIFIC CORPORATION
$661
Boston Scientific Corporation
$549
Veran Medical Technologies, Inc.
$440
Serpex Medical Inc
$431
Noah Medical Corporation
$342
Maquet Cardiovascular U.S. Sales, L.L.C.
$177
Covidien LP
$159
Ambu Inc.
$118
Philips North America LLC
$97
Ethicon US, LLC
$81
ICU Medical Inc
$16
Genentech USA, Inc.
$14
Medtronic, Inc.
$12
Top 3 companies account for 83.1% of all-time payments
Associated products mentioned in payments ›
(BI2) IGT Systems Undivided · 120V · 60Hz · ACQUIRE · Acquire · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHARTIS CATHETER · CRE · Da Vinci Surgical System · EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE · EXALT Model D · EXPECT · GALAXY · GENERAL PULMONARY · GENERAL BRONCHIAL THERMOPLASTY · GENERAL PULMONARY · LungVision · MONARCH · Monarch · Monarch Platform · Neuwave · Olympus Bronchoscopes · Olympus Capital Accessories · Olympus EBUS Bronchoscopes · Olympus Respiratory Accessories · Pulmonx Endobronchial Valve EBV · Respiratory Accessories · SINGLE USE SUCTION VALVE (Sterile) · SPiN Thoracic Navigation System · Single Use Guide Sheath Kit · Spiration Valve System · SuperDimension · ULTRAFLEX · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · iCAST · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pulmonary disease in OH.

Looking for a pulmonary disease specialist in Cleveland?
Compare pulmonary diseases in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Machuzak is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Machuzak experienced with lung biopsy via endoscope, 1 lobe?
Based on Medicare claims data, Dr. Machuzak performed 34 lung biopsy via endoscope, 1 lobe services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Machuzak receive payments from pharmaceutical companies?
Yes. Dr. Machuzak received a total of $327,532 from 25 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Machuzak's costs compare to other pulmonary diseases in Cleveland?
Dr. Machuzak's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Machuzak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →